ProShares - UltraShort Health Care (RXD) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, ProShares - UltraShort Health Care (RXD) es una empresa del sector Financial Services valorada en 0. Calificado con 47/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 18 mar 2026ProShares - UltraShort Health Care (RXD) Perfil de Servicios Financieros
ProShares UltraShort Health Care (RXD) is a geared ETF providing -2x daily exposure to the S&P Health Care Select Sector Index, appealing to sophisticated investors seeking short-term, inverse exposure to the health care sector. It offers a tactical tool for hedging or potentially profiting from anticipated downturns in the health care market.
Tesis de Inversión
ProShares UltraShort Health Care (RXD) presents a tactical opportunity for investors with a bearish outlook on the health care sector. The fund's -2x leverage offers the potential for amplified gains when the S&P Health Care Select Sector Index declines. However, this leverage also magnifies losses if the index rises. Key considerations include the fund's daily reset feature, which can lead to performance erosion over longer holding periods, particularly in volatile markets. Investors should closely monitor health care sector trends, regulatory changes, and economic factors that could impact the index. RXD is best suited for short-term trading strategies and hedging purposes, rather than long-term investment.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- RXD seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the S&P Health Care Select SectorSM Index.
- The fund is designed for sophisticated investors with a high-risk tolerance and a short-term trading horizon.
- RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day.
- Due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets.
- The fund's beta is -1.09, indicating an inverse correlation with the market.
Competidores y Pares
Fortalezas
- Leveraged inverse exposure provides the potential for high returns in a declining health care market.
- Intraday liquidity allows for flexible trading strategies.
- Established brand recognition in the ETF market.
Debilidades
- Leverage magnifies losses if the health care sector rises.
- Daily reset can lead to performance erosion over longer periods.
- High expense ratio compared to non-leveraged ETFs.
Catalizadores
- Upcoming: Potential for increased volatility in the health care sector due to upcoming regulatory changes.
- Ongoing: Continued economic uncertainty and geopolitical risks driving demand for inverse ETFs.
- Ongoing: Technological disruptions in the health care industry creating opportunities for short-term trading strategies.
Riesgos
- Potential: Unexpected rallies in the health care sector leading to significant losses.
- Potential: Changes in regulations governing leveraged ETFs.
- Ongoing: High expense ratio compared to non-leveraged ETFs.
- Ongoing: Daily reset leading to performance erosion over longer periods.
Oportunidades de crecimiento
- Increased Volatility in Healthcare Sector: Ongoing: The healthcare sector is subject to regulatory changes, drug pricing debates, and technological advancements, all of which can create volatility. RXD can capitalize on increased volatility as investors seek to hedge their portfolios or profit from short-term declines. The market size for inverse ETFs is directly correlated with market volatility, and the healthcare sector is expected to remain volatile due to political and economic factors.
- Rising Interest Rates: Ongoing: Rising interest rates can negatively impact growth stocks, including those in the healthcare sector. RXD can benefit from this trend as investors seek to hedge their exposure to healthcare companies that are sensitive to interest rate changes. The market for inverse ETFs that target interest rate-sensitive sectors is expected to grow as the Federal Reserve continues to tighten monetary policy.
- Geopolitical Risks: Ongoing: Geopolitical tensions and trade disputes can create uncertainty in global markets, leading to increased demand for safe-haven assets and inverse ETFs. RXD can benefit from this trend as investors seek to protect their portfolios from geopolitical risks. The market size for inverse ETFs that target specific sectors or countries is expected to grow as geopolitical risks remain elevated.
- Technological Disruption in Healthcare: Ongoing: Rapid technological advancements in healthcare, such as artificial intelligence and telemedicine, can disrupt traditional healthcare business models. RXD can capitalize on this disruption as investors seek to profit from the decline of companies that are slow to adapt to technological changes. The market for inverse ETFs that target disrupted industries is expected to grow as technology continues to transform the global economy.
- Increased Adoption of Short-Term Trading Strategies: Ongoing: The rise of online trading platforms and mobile apps has made it easier for investors to engage in short-term trading strategies. RXD is well-suited for short-term trading due to its leveraged inverse exposure. The market for leveraged and inverse ETFs is expected to grow as more investors adopt short-term trading strategies.
Oportunidades
- Increased volatility in the health care sector due to regulatory changes and economic uncertainty.
- Growing demand for inverse ETFs as investors seek to hedge their portfolios.
- Expansion into new markets and product offerings.
Amenazas
- Changes in regulations governing leveraged ETFs.
- Increased competition from other ETF providers.
- Unexpected rallies in the health care sector.
Ventajas competitivas
- First-mover advantage in offering leveraged inverse exposure to the S&P Health Care Select Sector Index.
- Established brand recognition in the ETF market.
- Proprietary trading strategies and risk management expertise.
Acerca de RXD
ProShares UltraShort Health Care (RXD) is designed for sophisticated investors seeking to achieve a multiple of the inverse of the daily performance of a specific index. Specifically, RXD aims to deliver two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index, before fees and expenses. This fund is not intended for long-term investment and is best suited for investors with a high-risk tolerance and a short-term trading horizon. The S&P Health Care Select Sector Index represents the health care sector of the S&P 500, including companies from industries such as pharmaceuticals, biotechnology, health care equipment, and health care services. RXD provides a way for investors to potentially profit from a decline in the value of these companies, using a leveraged inverse strategy. As an ETF, RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day. However, due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets. Investors should carefully monitor their positions and understand the risks associated with leveraged and inverse ETFs.
Qué hacen
- Provides leveraged inverse exposure to the S&P Health Care Select Sector Index.
- Offers a way to potentially profit from short-term declines in the health care sector.
- Designed for sophisticated investors with a high-risk tolerance.
- Trades like a stock on major exchanges.
- Offers intraday liquidity.
- Resets daily, which can lead to performance erosion over longer periods.
Modelo de Negocio
- RXD generates revenue through management fees charged to investors.
- The fund's performance is directly linked to the performance of the S&P Health Care Select Sector Index.
- The fund uses a leveraged inverse strategy to amplify its returns.
Contexto de la Industria
The asset management industry is characterized by intense competition, with firms vying for market share based on investment performance, fees, and product innovation. ETFs like RXD offer specialized exposure to specific sectors or investment strategies, catering to investors with diverse risk appetites and investment objectives. The health care sector, in particular, is subject to regulatory scrutiny and market volatility, creating opportunities for inverse ETFs like RXD to capitalize on short-term declines. The industry faces ongoing pressure to reduce fees and improve transparency, driving innovation in product design and distribution.
Clientes Clave
- Sophisticated investors
- High-risk tolerance traders
- Investors seeking short-term exposure to the health care sector
- Investors hedging their portfolios against potential declines in health care stocks
Finanzas
Gráfico e información
Precio de la acción de ProShares - UltraShort Health Care (RXD): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para RXD.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para RXD.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para RXD.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de RXD en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
RXD Preguntas Frecuentes sobre Acciones de Financial Services
¿Cuáles son los factores clave para evaluar RXD?
ProShares - UltraShort Health Care (RXD) actualmente tiene una puntuación IA de 47/100, indicando puntuación baja. Fortaleza clave: Leveraged inverse exposure provides the potential for high returns in a declining health care market.. Riesgo principal a monitorear: Potential: Unexpected rallies in the health care sector leading to significant losses.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de RXD?
RXD actualmente puntúa 47/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de RXD?
Los precios de RXD se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre RXD?
La cobertura de analistas para RXD incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en RXD?
Las categorías de riesgo para RXD incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Unexpected rallies in the health care sector leading to significant losses.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de RXD?
La relación P/E para RXD compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está RXD sobrevalorada o infravalorada?
Determinar si ProShares - UltraShort Health Care (RXD) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de RXD?
ProShares - UltraShort Health Care (RXD) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- The AI analysis is pending and will provide further insights into the company's performance and outlook.
- Leveraged and inverse ETFs are complex financial instruments and are not suitable for all investors.